Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joshua Olson

Plastic and Reconstructive Surgery Gilbert, AZ Medical Doctor

NPI 1831334861 CMS profile 173663

1482 E Williams Field Rd, Suite B101, Gilbert, AZ 85295

Open in the dashboard

General payments

$8,883

191 records reported · program years 2019–2025

Research payments

$750

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$13,014 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Joshua Olson of Gilbert, AZ is reported in the CMS Open Payments database as having received $8,883 across 191 general payments and $750 in research payments paid to them. Separately, studies naming them as principal investigator received $13,014 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 82nd percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,752 37
2024 General $2,076 30
2023 General $625 17
2022 General $1,163 35
2022 Research $750 1
2021 General $1,098 32
2020 General $310 17
2019 General $858 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joshua Olson
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Joshua Olson were reported at $2,752. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Joshua Olson Plastic and Reconstructive Surgery median Middle half National median
2019 $858 $335 $121–$1,264 $163
2020 $310 $162 $57–$417 $114
2021 $1,098 $245 $89–$735 $132
2022 $1,163 $325 $120–$932 $149
2023 $625 $343 $129–$999 $160
2024 $2,076 $390 $141–$1,085 $164
2025 $2,752 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $3,695 67 payments
  2. Sientra, Inc. $1,329 23 payments
  3. Motiva USA, LLC $1,113 6 payments
  4. Mentor Worldwide LLC $1,064 26 payments
  5. Allergan Inc. $1,043 55 payments
  6. Galderma Laboratories, L.P. $446 9 payments
  7. Davol Inc. $147 3 payments
  8. Merz North America, Inc. $28 1 payment
  9. Pacira Pharmaceuticals Incorporated $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,473 186 payments
  2. Travel and Lodging $2,410 5 payments
Products named General payments · program years 2019–2025
  1. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $4,772 49 payments
  2. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $1,565 8 payments
  3. REVOLVE $1,565 8 payments
  4. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $1,329 23 payments
  5. Motiva Implant Matrix $1,113 6 payments
  6. MENTOR MemoryGel Resterilizable Gel Sizer $819 19 payments
  7. BOTOX $580 33 payments
  8. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $256 11 payments
  9. NATRELLE $199 9 payments
  10. MemoryGel Breast Implants $186 6 payments
  11. Other $376 17 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Sientra, Inc. $750 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

48

Median for General Surgery: 59

Drug cost

$377

Median for General Surgery: $393

Branded share of claims

35.4%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 17 $166
Cephalexin Generic 20 $115
Cyclobenzaprine Hcl Generic 11 $96

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
  • AbbVie, Inc. $35
$35 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

192 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record